Claim OwnershipCECOG Academy Podcasts
Subscribed: 3Played: 9
Subscribe
© 2023 CECOG Academy
Description
CECOG has been formed to further the performance of clinical trials according to highest standards and to foster medical education in the area of oncology to the benefit for cancer patients in Central and Southeastern Europe and beyond.
24 Episodes
Reverse
Future approaches to BRCA testing - investigations into app-based testing
eHealth model
Group consenting model
Telegenetics model
Alternative models for genetic consenting
mainstream BRCA genetics: Learnings from an oncogenetic pathway
Practical approach to mainstream consenting
Knowledge of genetics required by healthcare professionals prior to mainstream consenting
The importance of mainstream cpnsenting
What is mainstream genetic consenting?
How is genetic consenting performed?
Why is genetic consenting important?
What is genetic consenting?
Targeted treatment options to improve outcomes in EGFRm NSCLCHost: Doz. Dr. Christiane ThallingerUniv. Prof Dr. Martin FilipitsInstitute of Cancer ResearchDepartment of Medicine IMedical University of ViennaUniv. Prof. Dr Bojan ZaricInstitute for Pulmonary Diseases of VojvodinaFaculty of MedicineUniversity of Novi Sad, Serbia
Zoom in for HER2+ space: Pharmacology & clinical (efficacy and safety) for trastuzumab deruxtecan Later lines of treatmentHost: Doz. Dr. Christiane ThallingerUniv. Prof. Dr. Evandro De AzambujaInstitut Jules BordetBelgiumUniv. Prof. Dr. Christoph ZielinskiProfessor of Medical Oncology and Clinical ImmunologyMedical Director, Wiener Privatklinik and Central European Cancer CenterWien, AustriaPresident, Central European Cooperative Oncology Group (CECOG)Editor in Chief, "ESMO Open - Cancer Horizons", 2016-2021
Clinical implementation of immuno-oncology therapy in unresectable stage III NSCLCHost: Doz. Dr. Christiane ThallingerUniv. Prof.Dr. Tanja CuferUniversity Clinic GolnikMedical Faculty LjubljanaSloveniaUniv. Prof. Dr. Rafal DziadziuskoDepartment of Oncology and RadiotherapyMedical University of Gdansk
How new treatments are impacting the work of Multidisciplinary Teams (MTD) (incl guidelines discussion)Host: Doz. Dr. Christiane ThallingerSpeakers:Dr. Mila PetrovaMHAT NadezhdaSofia, BulgariaUniv. Prof. Dr. Christoph ZielinskiProfessor of Medical Oncology and Clinical ImmunologyMedical Director, Wiener Privatklinik and Central European Cancer CenterWien, AustriaPresident, Central European Cooperative Oncology Group (CECOG)Editor in Chief, "ESMO Open - Cancer Horizons", 2016-2021
Changing the ES-SCLC Paradigm with Immuno-Oncology CombinationsHost: Doz. Dr. Christiane ThallingerSpeakers:Univ. Prof. Dr. Marko JakopovicThoracic Oncology Unit Department for Respiratory DiseasesUniversity Hospital Centre Zagreb, CroatiaUniv Prof Dr. Wolfgang Köstler Department of Medicine I,Clinical Division of Oncology,Medical University of Vienna, Austria
Patient needs in later lines of mBC (testing, efficacy of current treatment – what do we need)Host: Doz. Dr. Christiane ThallingerUniv. Prof. Dr. Rupert BartschDepartment of Medicine I,Clinical Division of Oncology,Medical University of Vienna, AustriaDr. Alexandru Eniu, MD, PhDHÔPITAL RIVIERA-CHABLAIS, VAUD-VALAIS,Spécialiste FMH en oncologie médicaleMédecin chef - Responsable Breast UnitSwitzerland
PANCREAS CANCER ACADEMY 2020 - Panel discussion: Advocates only
Comments
Download from Google Play
Download from App Store
United States